Sort   by:  
 Page size 
Primary human astrocytes were infected with either monkeypox virus (MPXV clade IIb lineage), vaccinia virus (VACV: Acambis 2000), or controls (MC=monkeypox control, AC = Vaccinia control) at an MOI of 10 for 6 h. Samples (n=4) were analyzed by LC-MS/MS with label-free quantification where the data w...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2023-06-21 | MSV000092229 | MassIVE
Subtiligase-based N-terminomics study with 0.5 uM SARS-CoV-2 Mpro in Jurkat cell lysates. Independent duplicates were injected with (L20200924-06, L20200924-07) and without FAIMS (L20200927-01-001, L20200927-02-002).
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2021-12-17 | MSV000088584 | MassIVE
Subtiligase-based N-terminomics study with 0.5 uM of recombinant SARS-CoV-2 Mpro in A549 cell lysates, in duplicate experiments.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2021-12-17 | MSV000088583 | MassIVE
Subtiligase based N-terminomics (Abu N-terminal tagging) of two A549 cell lysate replicates incubated with SARS-CoV-2 PLpro.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2022-08-12 | MSV000090125 | MassIVE
Subtiligase based reverse N-terminomics (Abu N-terminal tagging) of two Jurkat cell lysate replicates incubated with SARS-CoV-2 PLpro.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2022-08-12 | MSV000090124 | MassIVE
HAP1 cells with an NMT1, NMT2, or double knockout (as well as wildtype controls) were prepared by in-gel trypsin digestion and analyzed by LC-MS/MS label-free quantification (data-dependent acquisition). Additionally, HAP1 cells were treated with PCLX-001, an NMT inhibitor, at EC50 and EC90 (as well...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2023-05-10 | MSV000091913 | MassIVE
Sort   by:  
 Page size